Tag: HPV
-
Martin Kast’s Lasting Impact on HPV Vaccines and Cancer Education
Pioneering Research on HPV and Cancer Professor W. Martin Kast, the Walter A. Richter Cancer Research Chair at the University of Southern California, has spent more than two decades advancing our understanding of human papillomavirus (HPV) and its link to cancer. His work spans from basic science to translational efforts that bring discoveries from the…
-
Martin Kast’s Impact on HPV Vaccines and Cancer Education
Overview: A Pioneer in HPV Research and Cancer Education Professor W. Martin Kast, the Walter A. Richter Cancer Research Chair at the University of Southern California, has spent more than twenty years advancing our understanding of human papillomavirus (HPV)–related cancers and pioneering new approaches to immunotherapy. His work spans basic science, translational research, and education,…
-
A 44-Case Study (2020–2024): Gynecologic Cancer in HIV-Infected Patients Under ART
Introduction As antiretroviral therapy (ART) has transformed HIV from a fatal diagnosis into a manageable chronic condition, the health landscape for people living with HIV (PLWH) has changed dramatically. Among the shifts is a rising visibility of non-AIDS-defining cancers, including gynecologic malignancies. This study analyzes 44 clinical cases from 2020 through 2024 to understand how…
-
Gynecological Malignancies in HIV Patients: Insights from 44 Cases (2020–2024)
Introduction and context The advent of antiretroviral therapy (ART) has markedly extended the life expectancy of people living with HIV (PLWH). As survival improves, non-AIDS-defining cancers, including gynecological malignancies, have emerged as a significant cause of morbidity and mortality in this population. A focused study reviewing 44 cases from 2020 to 2024 provides important clues…
-
HPV self-testing set to revolutionise cervical cancer detection in Kenya
Kenya embraces a new era in cervical cancer screening In a country where cervical cancer remains a leading cause of cancer-related deaths among women, Kenya is piloting a bold move: HPV self-testing that women can perform at home or in community clinics. The program aims to overcome barriers that have long hindered screening—fear, stigma, distance…
-
HPV Self-Testing Set to Revolutionise Cervical Cancer Detection in Kenya
Introduction: A new wave in cervical cancer screening In Kenya, a quiet but powerful shift is underway in the fight against cervical cancer. HPV self-testing kits are being introduced as a practical, accessible alternative to traditional clinic-based screening. For women like 33-year-old clinical officer and mother of two, the impact is personal as well as…
-
Federal Guidelines Expand Cervical Cancer Screening with Self-Swab HPV Test
New federal guidance broadens cervical cancer screening options Federal health officials have announced updated recommendations that expand how people can screen for cervical cancer. The Health Resources and Services Administration (HRSA), part of the broader Health and Human Services system, released guidelines allowing self-collected HPV tests as a valid option for cervical cancer screening in…
-
New Federal Guidelines Embrace Self-Swab HPV Testing for Cervical Cancer Screening
Introduction: A Shift in Cervical Cancer Screening Federal health officials are expanding the toolbox for cervical cancer screening beyond the traditional Pap smear. The Health Resources and Services Administration (HRSA), part of the U.S. Department of Health and Human Services, released new recommendations that include the option of patient self-collected HPV testing. This move aims…
-
HPV Milestone, Measles Progress and Worsening Cholera Outbreak: Weekly African Health Update
HPV vaccination gains across Africa mark a significant milestone Across Africa, vaccination campaigns against the Human Papillomavirus (HPV) are expanding, signaling a notable shift in the continent’s battle against HPV-related diseases. Health ministries report increased vaccine uptake among school-age girls and, in several countries, expanded eligibility to older cohorts as part of catch-up programs. Experts…
-
Nanovaccine Promises New Hope Against HPV-Related Cancers
Groundbreaking Nanovaccine Targets HPV-Driven Cancers A new nanovaccine approach developed by researchers at UT Southwestern Medical Center has demonstrated remarkable efficacy against cancers caused by human papillomavirus (HPV) in a late-stage animal model. The study, described by the team as a significant step toward treating HPV-related malignancies, reports tumor eradication in animals with advanced, metastatic…